Near-infrared intraoperative imaging for minimally invasive pulmonary metastasectomy for sarcomas

J Thorac Cardiovasc Surg. 2019 May;157(5):2061-2069. doi: 10.1016/j.jtcvs.2018.10.169. Epub 2018 Dec 14.

Abstract

Background: Complete pulmonary metastasectomy for sarcoma metastases provides patients an opportunity for long-term survival and possible cure. Intraoperative localization of preoperatively identified metastases and identification of occult lesions can be challenging. In this trial, we evaluated the efficacy of near-infrared (NIR) intraoperative imaging using second window indocyanine green during metastasectomy to identify known metastases and to detect occult nodules.

Methods: Thirty patients with pulmonary nodules suspicious for sarcoma metastases were enrolled in an open-label, feasibility study (NCT02280954). All patients received intravenous indocyanine green (5 mg/kg) 24 hours before metastasectomy. Patients 1 through 10 (cohort 1) underwent metastasectomy via thoracotomy to assess fluorescence patterns of nodules detected by traditional methods (preoperative imaging and intraoperative visualization/bimanual palpation). After confirming reliability within cohort 1, patients 11 through 30 (cohort 2) underwent video-assisted thoracic surgery metastasectomy with NIR imaging.

Results: In cohort 1, 14 out of 16 preoperatively identified pulmonary metastases (87.5%) displayed tumor fluorescence. Nonfluorescent metastases were deeper than fluorescent metastases (2.1 cm vs 1.3 cm; P = .03). Five out of 5 metastases identified during thoracotomy displayed fluorescence. NIR imaging identified 3 additional occult lesions in this cohort. In cohort 2, 33 out of 37 known pulmonary metastases (89.1%) displayed fluorescence. Nonfluorescent tumors were deeper than 2.0 cm (P = .007). NIR imaging identified 24 additional occult lesions. Of 24 occult lesions, 21 (87.5%) were confirmed metastases and the remaining 3 nodules were lymphoid aggregates.

Conclusions: NIR intraoperative imaging with indocyanine green (5 mg/kg and 24 hours before surgery) localizes known sarcoma pulmonary metastases and identifies otherwise occult lesions. This approach may be a useful intraoperative adjunct to improve metastasectomy.

Keywords: ICG; intraoperative imaging; metastasectomy; optical imaging; sarcoma.

Publication types

  • Clinical Trial
  • Webcast

MeSH terms

  • Adult
  • Aged
  • Feasibility Studies
  • Female
  • Fluorescent Dyes / administration & dosage
  • Humans
  • Indocyanine Green / administration & dosage
  • Lung Neoplasms / diagnostic imaging
  • Lung Neoplasms / secondary
  • Lung Neoplasms / surgery*
  • Male
  • Metastasectomy / adverse effects
  • Metastasectomy / methods*
  • Middle Aged
  • Multiple Pulmonary Nodules / diagnostic imaging
  • Multiple Pulmonary Nodules / secondary
  • Multiple Pulmonary Nodules / surgery*
  • Optical Imaging / methods*
  • Pneumonectomy* / adverse effects
  • Predictive Value of Tests
  • Reproducibility of Results
  • Sarcoma / diagnostic imaging
  • Sarcoma / secondary
  • Sarcoma / surgery*
  • Solitary Pulmonary Nodule / diagnostic imaging
  • Solitary Pulmonary Nodule / secondary
  • Solitary Pulmonary Nodule / surgery*
  • Spectroscopy, Near-Infrared*
  • Thoracic Surgery, Video-Assisted* / adverse effects
  • Thoracotomy* / adverse effects
  • Time Factors
  • Treatment Outcome
  • Tumor Burden
  • Young Adult

Substances

  • Fluorescent Dyes
  • Indocyanine Green